Interferon-Gamma-Induced RANTES Production by Human Keratinocytes Is Enhanced by IL-1β, TNF-α, IL-4 and IL-13 and Is Inhibited by Dexamethasone and Tacrolimus
- 23 May 2001
- journal article
- pharmacology and-treatment
- Published by S. Karger AG in Dermatology
- Vol. 202 (3) , 239-245
- https://doi.org/10.1159/000051644
Abstract
Background and Methods: Recent studies have shown that RANTES plays a role in the pathogenesis of inflammatory skin diseases. We examined the production of RANTES by human keratinocytes (KCs) when cultured with various cytokines. Results: IFN-γ (100 ng/ml) or IL-1β (100 ng/ml) significantly induced RANTES production by KCs in 48-hour culture. These cytokines synergistically increased RANTES production by KCs. TNF-α (100 ng/ml), IL-4 (100 ng/ml) or IL-13 (100 ng/ml) markedly enhanced the RANTES production by KCs induced by IFN-γ (100 ng/ml) although none of those cytokines significantly enhanced that induced by IL-1β (100 ng/ml) in 48-hour culture. Dexamethasone (10–8 M) strongly inhibited RANTES production by KCs induced by the combination of IFN-γ and IL-4, while tacrolimus (FK-506, 10–8 and 10–6 M) showed partial inhibition. Conclusions: These results revealed that RANTES production by KCs is regulated by inflammatory cytokines, such as IFN-γ, IL-1β, TNF-α, IL-4 and IL-13, and can be modulated by immunosuppressive drugs. Our data suggest that RANTES is involved in skin inflammation.Keywords
This publication has 4 references indexed in Scilit:
- Chemokines induce eosinophil degranulation through CCR-3Journal of Allergy and Clinical Immunology, 2000
- Upregulation of RANTES in Psoriatic Keratinocytes: a Possible Pathogenic Mechanism for PsoriasisActa Dermato-Venereologica, 1999
- Tacrolimus (FK 506)--a new therapeutic agent for severe recalcitrant psoriasisArchives of Dermatology, 1992
- Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTESNature, 1990